In addition, MLIF decreased cerebral infarction areas and the level of malondialdehyde (MDA), myeloperoxidase (MPO), tumor necrosis factor-alpha (TNF-α), and IL-1β and increased the level of superoxide dismutase (SOD) (Yao et al., 2011). The gene discussed is TNF; the disease is cerebral infarction.